Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Innocan Pharma Corp (OP: INNPF ) 0.1055 UNCHANGED Last Price Updated: 9:30 AM EDT, Oct 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Innocan Pharma Corp < Previous 1 2 Next > CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark May 28, 2024 Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance. Via Benzinga This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain April 23, 2024 Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the U.S. Food and Drug Administration... Via Benzinga Exposures Product Safety 534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations April 02, 2024 Innocan Pharma's 2023 earnings report: Revenue soars 534%, operating loss down 61%, $1.5M capital raise. CEO shares strategic vision. Via Benzinga CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval February 13, 2024 Cannabinoid-focused pharmaceutical company Innocan Pharma Corp expects preliminary revenues of $4.89m in Q4 of fiscal 2023, representing a YoY increase of 331%. It said preliminary revenues are... Via Benzinga Exposures Product Safety 4 CBD Stocks in the Canadian Capital Market November 02, 2021 Photo by Via Benzinga Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 December 22, 2023 This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and... Via Benzinga Topics Cannabis Exposures Cannabis More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It October 23, 2023 Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has closed the second and final tranche of its previously announced private placement offering of its units. Via Benzinga Topics Cannabis Exposures Cannabis Product Safety CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare September 21, 2023 Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has entered into an agreement with Research Capital Corporation as the sole agent and sole book-runner on a "best efforts" agency basis... Via Benzinga Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales August 28, 2023 Innocan Pharma Corporation (CSE: INNO)(FSE: IP4) (OTC: INNPF), a pharmaceutical technology firm specializing in innovative drug delivery platforms, Via Benzinga Cannabis Stock Gainers And Losers From August 25, 2023 August 25, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Innocan Pharma Secures $1.4M Via Private Placement August 04, 2023 Innocan Pharma Corporation (OTC: INNPF) (CSE:INNO) (FSE:IP4) has closed a non-brokered private placement offering of 8.4 million units of Innocan at a price of CA$0.23 per unit Via Benzinga Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Innocan Pharma To Secure Up To $3M Via Private Placement Of Units At A 9% Prime Above Share Price July 25, 2023 Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) intends to complete a non-brokered private placement of up to 17.22 million units of the company at a price of CA$0.23 per unit fo Via Benzinga Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers August 17, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Movers For July 21, 2023 July 21, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 14, 2023 August 14, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Innocan Pharma Q1 Revenue Grows 500%, Here Is What You Need To Know June 01, 2023 Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) released its financial results for the three months ended March 31, 2023, revealing revenue of $1.6 million, an increase of 500%, Via Benzinga Cannabis Stock Gainers And Losers From August 11, 2023 August 11, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Innocan Pharma FY22 Revenue Grows 1205% To $2.6M, Here Is What You Need To Know April 19, 2023 Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) released its audited financial results for the year ended December 31,2022, revealing revenue of $2.6 million, an increase of 1205% from... Via Benzinga Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success February 21, 2023 Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) reported clinical success in its Canine (dogs) Compassionate Care Trial, resulting in improving walking abilities and significant decrease... Via Benzinga Innocan Pharma Q3 Revenue Grows 700% YoY, Here Is What You Need To Know November 29, 2022 Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) released its financial results for the three and nine months ended September 30, 2022, revealing Q3 revenue of $1.42 million, a 700% Via Benzinga Innocan Pharma Provides an Operational Update September 21, 2022 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 21, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... Via Newsfile Topics Intellectual Property Exposures Intellectual Property Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment September 09, 2022 A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant)... Via Newsfile Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 September 06, 2022 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals September 03, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021 August 27, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 27, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University August 18, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada August 11, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT) August 03, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss July 28, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
